120 related articles for article (PubMed ID: 23023513)
1. Letter to the editor on NaV1.8.
Numann RE; Gibson JK
Circ Res; 2012 Sep; 111(8):e230; author reply e231. PubMed ID: 23023513
[No Abstract] [Full Text] [Related]
2. Whither art thou, SCN10A, and what art thou doing?
London B
Circ Res; 2012 Jul; 111(3):268-70. PubMed ID: 22821905
[No Abstract] [Full Text] [Related]
3. Blocking Scn10a channels in heart reduces late sodium current and is antiarrhythmic.
Yang T; Atack TC; Stroud DM; Zhang W; Hall L; Roden DM
Circ Res; 2012 Jul; 111(3):322-32. PubMed ID: 22723299
[TBL] [Abstract][Full Text] [Related]
4. Ranolazine in Cardiac Arrhythmia.
Saad M; Mahmoud A; Elgendy IY; Richard Conti C
Clin Cardiol; 2016 Mar; 39(3):170-8. PubMed ID: 26459200
[TBL] [Abstract][Full Text] [Related]
5. Molecular charge associated with antiarrhythmic actions in a series of amino-2-cyclohexyl ester derivatives.
Pugsley MK; Yong SL; Goldin AL; Hayes ES; Walker MJA
Eur J Pharmacol; 2019 Feb; 844():241-252. PubMed ID: 30571955
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic management of arrhythmias.
Ganjehei L; Massumi A; Nazeri A; Razavi M
Tex Heart Inst J; 2011; 38(4):344-9. PubMed ID: 21841856
[No Abstract] [Full Text] [Related]
7. Safe and effective pharmacologic management of arrhythmias.
Razavi M
Tex Heart Inst J; 2005; 32(2):209-11. PubMed ID: 16107117
[No Abstract] [Full Text] [Related]
8. Inhibition of Late Sodium Current as an Innovative Antiarrhythmic Strategy.
Bengel P; Ahmad S; Sossalla S
Curr Heart Fail Rep; 2017 Jun; 14(3):179-186. PubMed ID: 28455610
[TBL] [Abstract][Full Text] [Related]
9. New insights into the pharmacology of sodium channel blockers.
Tamargo J; Valenzuela C; Delpón E
Eur Heart J; 1992 Nov; 13 Suppl F():2-13. PubMed ID: 1335869
[No Abstract] [Full Text] [Related]
10. Diprafenone.
Drugs R D; 1999 Apr; 1(4):301-3. PubMed ID: 10566049
[No Abstract] [Full Text] [Related]
11. [Ion channels and arrhythmias].
Borchard U; Hafner D
Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780
[TBL] [Abstract][Full Text] [Related]
12. Ranolazine: an antianginal drug with antiarrhythmic properties.
Tamargo J; Caballero R; Delpón E
Expert Rev Cardiovasc Ther; 2011 Jul; 9(7):815-27. PubMed ID: 21809962
[TBL] [Abstract][Full Text] [Related]
13. Relation between activation sequence fluctuation and arrhythmogenicity in sodium-channel blockades.
Watanabe T; Yamaki M; Kubota I; Tachibana H; Tomoike H
Am J Physiol; 1999 Sep; 277(3):H971-7. PubMed ID: 10484418
[TBL] [Abstract][Full Text] [Related]
14. Sodium channel blockers.
Kyle DJ; Ilyin VI
J Med Chem; 2007 May; 50(11):2583-8. PubMed ID: 17489575
[No Abstract] [Full Text] [Related]
15. Targeting sodium channels in cardiac arrhythmia.
Remme CA; Wilde AA
Curr Opin Pharmacol; 2014 Apr; 15():53-60. PubMed ID: 24721654
[TBL] [Abstract][Full Text] [Related]
16. Hot topics in cellular cardiac electrophysiology with potential impact on future drug design.
Nánási PP; Kecskeméti V
Curr Med Chem; 2011; 18(24):3595-6. PubMed ID: 21774766
[No Abstract] [Full Text] [Related]
17. Late sodium current dysregulation as a causal factor in arrhythmia.
Unudurthi SD; Hund TJ
Expert Rev Cardiovasc Ther; 2016; 14(5):545-7. PubMed ID: 26886049
[No Abstract] [Full Text] [Related]
18. Late INa Inhibition as an Antiarrhythmic Strategy.
Burashnikov A
J Cardiovasc Pharmacol; 2017 Sep; 70(3):159-167. PubMed ID: 28654510
[TBL] [Abstract][Full Text] [Related]
19. Ranolazine and late cardiac sodium current--a therapeutic target for angina, arrhythmia and more?
Makielski JC; Valdivia CR
Br J Pharmacol; 2006 May; 148(1):4-6. PubMed ID: 16520741
[TBL] [Abstract][Full Text] [Related]
20. An emerging antiarrhythmic target: late sodium current.
Banyasz T; Szentandrássy N; Magyar J; Szabo Z; Nánási PP; Chen-Izu Y; Izu LT
Curr Pharm Des; 2015; 21(8):1073-90. PubMed ID: 25354179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
